Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ＣＸＣＬ８結合核酸
Document Type and Number:
Japanese Patent JP2022512969
Kind Code:
A
Abstract:
本発明は、ヒトＣＸＣＬ８に結合することができるＬ－核酸分子に関し、Ｌ－核酸分子は、ヌクレオチドの中央ストレッチを含み、ヌクレオチドの中央ストレッチは、ヌクレオチド配列５’－ＧＧＡＡＧＵＡＣＧＵＧＧＡＡＡＧＣＣＲＡ（ＸＵ）ＲＡＧＵＧＵＧＵＣＣＣＧ－３’［配列番号２７］を含み、ここで、ＸＵはＵであるか、または存在しない。【選択図】図なし

More Like This:
WO/2018/013481RECOMBINANT POLYPEPTIDES COMPRISING SELENOCYSTEINE AND METHOD FOR PRODUCING THE SAME
WO/2018/014520PRIMERS, PROBES AND KIT FOR USE IN DETECTING C-KIT GENE MUTATIONS
WO/1999/053048DNA SEQUENCE IN THE Sp5 MUTANT AND SITE SPECIFIC GENETIC RECOMBINATION
Inventors:
Helich, chi
Vaiter, Axel
Pushek, Vune
Zvoralski, Dark
Maash, Christian
Application Number:
JP2021525070A
Publication Date:
February 07, 2022
Filing Date:
November 12, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Aptallion Biotech AG
International Classes:
C12N15/11; A61K31/7088; A61K47/60; A61K47/61; A61K47/62; A61K50/00; A61K51/04; A61P29/00; A61P35/00; C12Q1/6813; C12Q1/6825; G01N33/15; G01N33/50; G01N33/53; G01N33/531
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi



 
Previous Patent: Compositions and Methods for T Cell Manipulation

Next Patent: Biological inks and coatings, and related methods